PFIZER REPORTS FIRST-QUARTER 2016 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Pfizer (PFE) Tops Q1 EPS by 12c; Boosts FY16 Outlook
May 3, 2016 6:46 AM EDTPfizer (NYSE: PFE) reported Q1 EPS of $0.67, $0.12 better than the analyst estimate of $0.55. Revenue for the quarter came in at $13 billion versus the consensus estimate of $12 billion.
GUIDANCE:
Pfizer sees FY2016 EPS of $2.38 - $2.48, versus prior guidance of $2.20 - $2.30 and... More
